BRD2 and breast cancer: When blocking FSH release by a GnRH analog in hypothalamus for breast cancer patients, circulating adiponectin was further decreased compared with that in breast cancer patients receiving tamoxifen therapy only, suggesting that FSH has a role in adiponectin expression [40,41] in humans.